Inpharma

The influenza virus vaccine components for the 2001-2002 Northern hemisphere season have been decided
pp. 1-1(1)

Antiretrovirals: beware when interrupting treatment
pp. 2-2(1)

Shortage of tetanus vaccine in the US
pp. 2-2(1)

Stem cell transplantation - hope for patients with Parkinson's disease?
pp. 3-4(2)

There is no justification for refusing infertility therapy to patients with HIV infection
pp. 4-4(1)

Zanamivir: better inhalers needed for elderly patients
pp. 4-4(1)

Clinical trials of the first candidate HIV vaccine designed for use in Africa have begun
pp. 4-4(1)

UK NICE issues guidance on pioglitazone for type 2 diabetes
pp. 5-5(1)

UK NICE issues guidance on orlistat for obesity
pp. 5-5(1)

GlaxoSmithKline forms partnerships in malaria research
pp. 5-5(1)

Inhaled triamcinolone therapy linked to reduced antifungal use
pp. 6-6(1)

Dermatan sulfate dominant in DVT prophylaxis
pp. 6-6(1)

Combination ipratropium bromide/2-agonist inhaler cost saving
pp. 6-6(1)

SR 29142: effective hyperuricaemia prophylaxis and treatment
pp. 7-7(1)

Efavirenz triple therapy first choice for HIV infection?
pp. 7-7(1)

Surgical androgen suppression less costly in prostate cancer
pp. 7-7(1)

Febrile granulocytopenia: clinafloxacin and imipenem comparable
pp. 8-8(1)

ALT-711 reduces vascular stiffness and improves LV function
pp. 8-8(1)

A dithiosemicarbazone complex with radioactive copper may have potential in cancer therapy
pp. 8-8(1)

BAY 361677 inhibits the growth of acute lymphoblastic leukaemia (ALL) cells in vitro
pp. 8-8(1)

The T helper (Th) 1 inhibitor TAK-603 seems to attenuate acute graft-versus-host disease
pp. 8-8(1)

Activated protein C provides a new therapeutic option in sepsis
pp. 9-9(1)

Halofuginone for liver fibrosis prevention and treatment?
pp. 10-10(1)

Concurrent gemcitabine and radiotherapy is feasible in head and neck cancer
pp. 10-10(1)

Concurrent paclitaxel and radiotherapy is promising for the treatment of head and neck cancer
pp. 10-10(1)

Carvedilol beneficial in dialysis patients with dilated cardiomyopathy
pp. 10-10(1)

An update on thrombolytic therapy for acute stroke
pp. 11-12(2)

Menotropins effectively lower the miscarriage rate in women with a history of recurrent miscarriage
pp. 12-12(1)

Antithymocyte globulin plus mycophenolate mofetil (MMF) seems to be beneficial
pp. 12-12(1)

Which anthracycline dose optimal in node-positive breast cancer?
pp. 13-13(1)

Gender difference needed in threshold for antiretroviral initiation?
pp. 13-13(1)

Risperidone plus quetiapine was beneficial in a man with refractory schizophrenia
pp. 13-13(1)

Lung cancer news from the 11th International Congress on Anti-Cancer Treatment
pp. 14-15(2)

Carbamazepine seems to have efficacy in the treatment of peripheral neuropathic pain
pp. 15-15(1)

Vaginal misoprostol preferable for induction of labour?
pp. 15-15(1)

Abacavir- and indinavir-based regimens comparable?
pp. 16-16(1)

Topical alitretinoin effective in cutaneous KS lesions
pp. 16-16(1)

Mitoxantrone + carboplatin an option in ovarian cancer?
pp. 16-16(1)

Compliance with depot antipsychotics is associated with the severity of negative symptoms
pp. 17-17(1)

Letrozole: a possible option for ovulation induction
pp. 17-17(1)

The conventional and controlled-release GITS formulations of doxazosin are comparable
pp. 17-17(1)

Systemic lupus erythematosus (SLE) may recur after high-dose chemotherapy and HSCT
pp. 17-17(1)

Chemotherapy beneficial in pleural effusions from NSCLC
pp. 17-17(1)

Interferon (IFN)--2b is effective in patients with mild chronic hepatitis C
pp. 18-18(1)

Citalopram appears to be effective in the treatment of obsessive compulsive disorder
pp. 18-18(1)

Risperidone gets a tick for use in Tourette's syndrome
pp. 18-18(1)

Mycophenolate mofetil (MMF) is effective rescue therapy in paediatric liver transplant recipients
pp. 18-18(1)

Once-daily moxifloxacin is `equivalent' to amoxicillin 3 times daily in the treatment of CAP
pp. 18-18(1)

Low-dose esterified estrogen improves haemodynamics
pp. 19-19(1)

Desloratadine + erythromycin or ketoconazole: no ECG changes
pp. 19-19(1)

Tocopherol [vitamin E] supplementation does not seem to reduce oxidative stress
pp. 19-19(1)

Resistance of gonococci to ciprofloxacin seems to be increasing in the UK
pp. 19-19(1)

Reports of drug-induced neutropenia in Finland
pp. 20-20(1)

Phenobarbital to be suspended in France for nonepilepsy indications
pp. 20-20(1)

Autism not temporally related to MMR vaccination in California
pp. 20-20(1)

Concerns raised over LNG-IUS use in tamoxifen-treated women
pp. 21-21(1)

13 reports of accidental overdose due to prescribing or dispensing errors with alfacalcidol
pp. 21-21(1)

Amphotericin B: safer when infused continuously
pp. 21-21(1)

Merck & Co., Inc. has lowered its prices in developing countries for its 2 HIV drugs
pp. 22-22(1)

SC epoetin beta [`NeoRecormon'; Roche] has been issued a positive opinion
pp. 22-22(1)

The approved indications for Merck KGaA's metformin [`Glucophage'] have been extended
pp. 22-22(1)

Aurum Pharmaceuticals has launched its injectable amiodarone product in the UK
pp. 22-22(1)

A generic bioequivalent version of controlled-release diltiazem has been launched in Canada
pp. 22-22(1)

A generic ethinylestradiol/norethisterone [`Nortrel 7/7/7'; Barr Laboratories] product
pp. 22-22(1)

Recent product launches in Thailand
pp. 22-22(1)

Recent product approvals in the Australian market
pp. 22-22(1)